Fuenzalida, K.; Leal-Witt, M.J.; Guerrero, P.; Hamilton, V.; Salazar, M.F.; Peñaloza, F.; Arias, C.; Cornejo, V.
NTBC Treatment Monitoring in Chilean Patients with Tyrosinemia Type 1 and Its Association with Biochemical Parameters and Liver Biomarkers. J. Clin. Med. 2021, 10, 5832.
https://doi.org/10.3390/jcm10245832
AMA Style
Fuenzalida K, Leal-Witt MJ, Guerrero P, Hamilton V, Salazar MF, Peñaloza F, Arias C, Cornejo V.
NTBC Treatment Monitoring in Chilean Patients with Tyrosinemia Type 1 and Its Association with Biochemical Parameters and Liver Biomarkers. Journal of Clinical Medicine. 2021; 10(24):5832.
https://doi.org/10.3390/jcm10245832
Chicago/Turabian Style
Fuenzalida, Karen, MarÃa Jesús Leal-Witt, Patricio Guerrero, Valerie Hamilton, MarÃa Florencia Salazar, Felipe Peñaloza, Carolina Arias, and Verónica Cornejo.
2021. "NTBC Treatment Monitoring in Chilean Patients with Tyrosinemia Type 1 and Its Association with Biochemical Parameters and Liver Biomarkers" Journal of Clinical Medicine 10, no. 24: 5832.
https://doi.org/10.3390/jcm10245832
APA Style
Fuenzalida, K., Leal-Witt, M. J., Guerrero, P., Hamilton, V., Salazar, M. F., Peñaloza, F., Arias, C., & Cornejo, V.
(2021). NTBC Treatment Monitoring in Chilean Patients with Tyrosinemia Type 1 and Its Association with Biochemical Parameters and Liver Biomarkers. Journal of Clinical Medicine, 10(24), 5832.
https://doi.org/10.3390/jcm10245832
